FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3115335364> ?p ?o ?g. }

• W3115335364 endingPage "205" @default.
• W3115335364 startingPage "196" @default.
• W3115335364 abstract "Immune checkpoint inhibitors (ICIs) are widely used for various malignancies. However, their safety and efficacy in patients with a kidney transplant have not been defined. To delineate this, we conducted a multicenter retrospective study of 69 patients with a kidney transplant receiving ICIs between January 2010 and May 2020. For safety, we assessed the incidence, timing, and risk factors of acute graft rejection. For efficacy, objective response rate and overall survival were assessed in cutaneous squamous cell carcinoma and melanoma, the most common cancers in our cohort, and compared with stage-matched 23 patients with squamous cell carcinoma and 14 with melanoma with a kidney transplant not receiving ICIs. Following ICI treatment, 29 out of 69 (42%) patients developed acute rejection, 19 of whom lost their allograft, compared with an acute rejection rate of 5.4% in the non-ICI cohort. Median time from ICI initiation to rejection was 24 days. Factors associated with a lower risk of rejection were mTOR inhibitor use (odds ratio 0.26; 95% confidence interval, 0.09-0.72) and triple-agent immunosuppression (0.67, 0.48-0.92). The objective response ratio was 36.4% and 40% in the squamous cell carcinoma and melanoma subgroups, respectively. In the squamous cell carcinoma subgroup, overall survival was significantly longer in patients treated with ICIs (median overall survival 19.8 months vs. 10.6 months), whereas in the melanoma subgroup, overall survival did not differ between groups. Thus, ICIs were associated with a high risk of rejection in patients with kidney transplants but may lead to improved cancer outcomes. Prospective studies are needed to determine optimal immunosuppression strategies to improve patient outcomes." @default.
• W3115335364 created "2021-01-05" @default.
• W3115335364 creator A5000245370 @default.
• W3115335364 creator A5000484881 @default.
• W3115335364 creator A5000817838 @default.
• W3115335364 creator A5001780081 @default.
• W3115335364 creator A5013092298 @default.
• W3115335364 creator A5015498310 @default.
• W3115335364 creator A5018399640 @default.
• W3115335364 creator A5020460043 @default.
• W3115335364 creator A5021389051 @default.
• W3115335364 creator A5025441901 @default.
• W3115335364 creator A5029578541 @default.
• W3115335364 creator A5030834372 @default.
• W3115335364 creator A5032181570 @default.
• W3115335364 creator A5036875036 @default.
• W3115335364 creator A5039412326 @default.
• W3115335364 creator A5040646631 @default.
• W3115335364 creator A5041066193 @default.
• W3115335364 creator A5044045808 @default.
• W3115335364 creator A5045080405 @default.
• W3115335364 creator A5046186654 @default.
• W3115335364 creator A5046713982 @default.
• W3115335364 creator A5048669465 @default.
• W3115335364 creator A5049148114 @default.
• W3115335364 creator A5049876122 @default.
• W3115335364 creator A5055513055 @default.
• W3115335364 creator A5061551777 @default.
• W3115335364 creator A5064078212 @default.
• W3115335364 creator A5064106882 @default.
• W3115335364 creator A5064120425 @default.
• W3115335364 creator A5067253873 @default.
• W3115335364 creator A5067525628 @default.
• W3115335364 creator A5068130187 @default.
• W3115335364 creator A5071446768 @default.
• W3115335364 creator A5071593060 @default.
• W3115335364 creator A5072561852 @default.
• W3115335364 creator A5072768944 @default.
• W3115335364 creator A5073040359 @default.
• W3115335364 creator A5080022610 @default.
• W3115335364 creator A5080783554 @default.
• W3115335364 creator A5081552762 @default.
• W3115335364 creator A5083488593 @default.
• W3115335364 creator A5083826351 @default.
• W3115335364 creator A5084544284 @default.
• W3115335364 creator A5084967339 @default.
• W3115335364 creator A5085011627 @default.
• W3115335364 creator A5085204943 @default.
• W3115335364 creator A5085353457 @default.
• W3115335364 creator A5085982303 @default.
• W3115335364 creator A5086028754 @default.
• W3115335364 creator A5088223962 @default.
• W3115335364 date "2021-07-01" @default.
• W3115335364 modified "2023-10-16" @default.
• W3115335364 title "A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant" @default.
• W3115335364 cites W1520373882 @default.
• W3115335364 cites W1561521474 @default.
• W3115335364 cites W1819681752 @default.
• W3115335364 cites W1972517554 @default.
• W3115335364 cites W1974532798 @default.
• W3115335364 cites W1979627083 @default.
• W3115335364 cites W2051872988 @default.
• W3115335364 cites W2060070314 @default.
• W3115335364 cites W2112845420 @default.
• W3115335364 cites W2122346692 @default.
• W3115335364 cites W2126453999 @default.
• W3115335364 cites W2152897456 @default.
• W3115335364 cites W2303235652 @default.
• W3115335364 cites W2560367415 @default.
• W3115335364 cites W2572174216 @default.
• W3115335364 cites W2578082697 @default.
• W3115335364 cites W2747774814 @default.
• W3115335364 cites W2753432434 @default.
• W3115335364 cites W2805968856 @default.
• W3115335364 cites W2884453834 @default.
• W3115335364 cites W2888599070 @default.
• W3115335364 cites W2902665660 @default.
• W3115335364 cites W2918092070 @default.
• W3115335364 cites W2938409495 @default.
• W3115335364 cites W2949631428 @default.
• W3115335364 cites W2952666958 @default.
• W3115335364 cites W2980830192 @default.
• W3115335364 cites W2984413960 @default.
• W3115335364 cites W2994145616 @default.
• W3115335364 cites W2997561837 @default.
• W3115335364 cites W3005134677 @default.
• W3115335364 cites W3005182134 @default.
• W3115335364 cites W3037401306 @default.
• W3115335364 cites W3043703771 @default.
• W3115335364 cites W3044041426 @default.
• W3115335364 cites W4293241248 @default.
• W3115335364 doi "https://doi.org/10.1016/j.kint.2020.12.015" @default.
• W3115335364 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8222056" @default.
• W3115335364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33359528" @default.
• W3115335364 hasPublicationYear "2021" @default.
• W3115335364 type Work @default.
• W3115335364 sameAs 3115335364 @default.
• W3115335364 citedByCount "76" @default.

• next